Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > They didn't announce the IND's for oncology and NASH

<< Previous

Bullboard Posts

Next >>

Comment by Trogarzonon Apr 28, 2023 11:23am

56 Views

Post# 35419230

RE:RE:They didn't announce the IND's for oncology and NASH

Ask yourself what have they done for me. What has the board done for us. What has the CEO done for me.. do we have a deal for anything, do we have new products, do we have something else than the price increses on the legacy drugs, a hiring craze pre P1 pause than was seen as irresponsible. What have we got from our CFO, anything creative in terms of financing aprt from 15% bank margin that is full of bad covenants taht may end up costing us the whole company. They share price mirors what we got. and warrant they get what they deserve by voting.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland